Vertex Pharmaceuticals Incorporated (0QZU)
LSE
549.18
+9.51 (+1.76%)
Real-time Data
07:00 AM
Day's Range
539.46560.00
52 wk Range
375.33560.00
Financial Statements - 0QZU - Vertex Pharmaceuticals Incorporated
Revenue
1.37B▲ 10.7%
Net Income
221.04M▲ 49.1%Net Margin 16.1%
EBITDA
294.70M▲ 30.2%
Free Cash Flow
189.60M▲ 175.6%
Income Statement
| Period Ending | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|
| Sales | 1.37B | 1.23B | 1.59B | 1.68B |
| Cost of Goods | 503.85M | 512.77M | 678.57M | 703.93M |
| Gross Profit | 868.32M | 726.50M | 913.35M | 977.42M |
 Operating Expense | - | - | - | - |
| Operating Income | 267.62M | 225.66M | 298.74M | 341.81M |
| Non-Operating Interest | - | - | - | - |
| Other Income Expense | - | - | - | - |
| Pre Tax Income | 261.05M | 185.48M | 372.63M | 459.24M |
| Income Tax | 40M | 37.20M | 66.60M | 82.99M |
| Net Income | 221.04M | 148.28M | 306.02M | 376.24M |
| EPS Basic | 0.2251 | 0.151 | 0.3116 | 0.383096 |
| EPS Diluted | 0.2251 | 0.151 | 0.3116 | 0.383096 |
| Basic Shares Outstanding | 982.11M | 982.11M | 982.11M | 982.11M |
| Diluted Shares Outstanding | 982.11M | 982.11M | 982.11M | 982.11M |
| Ebit | - | - | - | - |
| Ebitda | 294.70M | 226.27M | 412.30M | 367.04M |
| Net Income Continuous Operations | 261.05M | 185.48M | 372.63M | 459.24M |
| Minority Interests | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
